Enterprise Solutions Webinars

  1. Avid Bioservices Capabilities Update June 2026: Cell Line Development 6/19/2026

    Explore how integrated cell line development and early-stage capabilities enable faster timelines while building a strong foundation for clinical and commercial success.

  2. FUJIFILM Biotechnologies June 2026 Capabilities Update: Microbial Development & Mfg 6/19/2026

    Explore FUJIFILM Biotechnologies’ process development capabilities that make reaching IND quickly a reality, while our experts work with you to create flexible approaches to BLA.

  3. WuXi Biologics Capabilities Update June 2026: Cell Line Development 6/19/2026

    Targeted integration improves titer, stability, and consistency in cell line development, accelerating timelines, reducing risk, and enabling scalable, data-driven CMC for complex biologics.

  4. Rentschler Biopharma Capabilities Update June 2026: Cell Line Development 6/19/2026

    Next-gen CMC uses high-performing cell lines to accelerate timelines, improve consistency, and scale efficiently, leveraging gains in stability, pool quality, and process intensification.

  5. Simplifying ADC Development Through CDMO Collaboration 6/17/2026

    Two CDMOs are working together to simplify ADC development. Learn how integrated support and collaboration can reduce complexity, streamline transfers, and keep programs moving forward.

  6. Elevate Your Protein Production With SynWeave™ 6/15/2026

    Sunit Maity, Ph.D., Senior GM – Biologics Services, introduces an advanced platform that combines state-of-the-art cell line and transposon-based technologies from ExcellGene.

  7. Integrated DS-DP Manufacturing For Your Biologics 6/15/2026

    Discover how next-generation biologics manufacturing can help accelerate your path from molecule to market with the scale, speed, and flexibility needed to support your program at every stage.

  8. Biologics DS Manufacturing Facility Across The U.S. And India 6/15/2026

    Our integrated setup enables seamless progression from early-stage development to commercial production, providing flexibility, scalability, and operational efficiency to accelerate biologics programs and support evolving market demands.

  9. Biologics DP Manufacturing Facility — 1M Vials Per Day 6/15/2026

    Our facility features two high-speed vial filling lines capable of producing up to one million vials per day, accommodating fill volumes ranging from 1 mL to 100 mL across a broad range of biologic products.

  10. The Hidden Challenges Of Biologics Development 6/11/2026

    Biologics development leaders discuss industry challenges, including innovation pressures, operational complexity, leadership decisions, and maintaining quality and resilience in an evolving landscape.